pubmed-article:12928393 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12928393 | lifeskim:mentions | umls-concept:C0851887 | lld:lifeskim |
pubmed-article:12928393 | lifeskim:mentions | umls-concept:C0085605 | lld:lifeskim |
pubmed-article:12928393 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
pubmed-article:12928393 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
pubmed-article:12928393 | lifeskim:mentions | umls-concept:C1704410 | lld:lifeskim |
pubmed-article:12928393 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:12928393 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
pubmed-article:12928393 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:12928393 | pubmed:dateCreated | 2003-8-20 | lld:pubmed |
pubmed-article:12928393 | pubmed:abstractText | Effects of adenoviral infection on in vivo responses to LPS mediated by TNF-alpha were evaluated in a murine model. Adenovirus-infected mice showed decreased mortality from fulminant hepatitis induced by administration of LPS or staphylococcal enterotoxin B in the presence of D-galactosamine. Importantly, TNF-alpha resistance genes within adenoviral E3 region were not required, because E1,E3-deleted vectors showed similar effects. Adenovirus-infected mice exhibited higher TNF-alpha levels after LPS stimulation, no difference in TNFR1 expression, and similar mortality from Fas-induced fulminant hepatitis. Decreased production of IL-6 and KC in response to exogenous TNF-alpha, in addition to protection from TNF-alpha, suggested that adenoviral infection results in TNF-alpha tolerance. | lld:pubmed |
pubmed-article:12928393 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:language | eng | lld:pubmed |
pubmed-article:12928393 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12928393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12928393 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12928393 | pubmed:month | Sep | lld:pubmed |
pubmed-article:12928393 | pubmed:issn | 0022-1767 | lld:pubmed |
pubmed-article:12928393 | pubmed:author | pubmed-author:MonickMartha... | lld:pubmed |
pubmed-article:12928393 | pubmed:author | pubmed-author:HunninghakeGa... | lld:pubmed |
pubmed-article:12928393 | pubmed:author | pubmed-author:ButlerNoah... | lld:pubmed |
pubmed-article:12928393 | pubmed:author | pubmed-author:YarovinskyTim... | lld:pubmed |
pubmed-article:12928393 | pubmed:author | pubmed-author:PowersLinda... | lld:pubmed |
pubmed-article:12928393 | pubmed:author | pubmed-author:BradfordMary... | lld:pubmed |
pubmed-article:12928393 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12928393 | pubmed:day | 1 | lld:pubmed |
pubmed-article:12928393 | pubmed:volume | 171 | lld:pubmed |
pubmed-article:12928393 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12928393 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12928393 | pubmed:pagination | 2453-60 | lld:pubmed |
pubmed-article:12928393 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:meshHeading | pubmed-meshheading:12928393... | lld:pubmed |
pubmed-article:12928393 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12928393 | pubmed:articleTitle | Adenoviral infection decreases mortality from lipopolysaccharide-induced liver failure via induction of TNF-alpha tolerance. | lld:pubmed |
pubmed-article:12928393 | pubmed:affiliation | Department of Internal Medicine, Division of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa, 100 EMRB, Iowa City, IA 52242, USA. timur-yarovinsky@uiowa.edu | lld:pubmed |
pubmed-article:12928393 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12928393 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:12928393 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12928393 | lld:pubmed |